جستجوی استاد راهنمای دانشگاهی

Matthew W. Buczynski is an Assistant Professor at the School of Neuroscience , part of the College of Science at Virginia Tech . Holding a Ph.D. in Biochemistry from the University of California San Diego (2008) and postdoctoral training at The Scripps Research Institute (2009-2016), he joined Virginia Tech in August 2016 after completing his postdoctoral fellowship. Education: B.S. in Chemistry, University of Michigan , 2001 Ph.D. in Biochemistry, University of California San Diego , 2008 Postdoctoral Training, The Scripps Research Institute , 2009-2016 Dr. Buczynski’s research program focuses on identifying novel druggable targets for addiction and neurological disorders through mass spectrometry and behavioral pharmacology . His work integrates chemical biology , molecular pharmacology , and in vivo microdialysis to study molecular changes in the brain during chronic drug exposure. Key areas include nicotine dependence , ethanol withdrawal , and cross-talk between pain and addiction mechanisms. His recent publications highlight endocannabinoid system modulation , TRPV1/TRPA1 receptor activation in pain, and diacylglycerol lipase (DAGL) mechanisms in nicotine withdrawal. He employs both self-administration and forced exposure models to validate therapeutic targets. Prospective students can contact him directly through his lab’s website .

• Neuroscience
• Drug Addiction
• Pharmacology
• +۳ مورد دیگر

Thomas Pap serves as Professor at the Department of Molecular Medicine within the Institute of Musculoskeletal Medicine (IMM) at the University of Muenster. He actively participates in the "Cells in Motion" research cluster and the Imaging Network, focusing on cell dynamics and imaging applications in musculoskeletal pathologies. His research centers on molecular mechanisms of inflammatory joint diseases, with key emphases on: Destructive arthritis pathogenesis through fibroblast transformation and adherens junction dynamics Regulation of alarmin activity (S100A8/S100A9) in sterile inflammation TRP channel modulation of osteoclast function and bone loss Translational models for tendon healing and microsurgical reconstruction Advanced imaging techniques for monitoring inflammatory lesions Analysis of his 2013-2021 publications reveals consistent interdisciplinary work bridging immunology, cell biology, and clinical applications. His studies frequently employ molecular imaging and translational models to investigate rheumatoid arthritis mechanisms, neutrophil chemotaxis, and bacterial immune evasion, with strong emphasis on therapeutic targeting of inflammatory pathways. The Pap Group operates within the Multiscale Imaging Centre (MIC), collaborating on pilot projects and the "Train Gain Fellowships" graduate program. Their work integrates with the university's broader Imaging Network, utilizing advanced microscopy and molecular techniques to study cell dynamics in inflammatory conditions.

• Rheumatology
• Inflammation
• Arthritis
• +۴ مورد دیگر

Manoj Upadhya is a Postdoctoral Research Associate at the Aston School of Life and Health Sciences, Aston University (UK). His research focuses on epilepsy, neuropharmacology, and neurodegenerative diseases, with expertise in rodent models, electrophysiology, and molecular biology. He holds a PhD from RTM Nagpur University (India) and has held roles including Assistant Professor in Pharmacology and Research positions at IISER Pune and Sun Pharma. Education : PhD (Role of CART peptide in Neurodegeneration), RTM Nagpur University, 2009–2013 Research Interests : Translational epilepsy research, autoimmune encephalitis, pain mechanisms, and neurodegenerative diseases using rodent models. Techniques include behavioral paradigms, electrophysiology, and confocal imaging. Key contributions include identifying therapeutic targets for Parkinson's, Alzheimer's, and Huntington's diseases. Articles Trends : Recent work emphasizes autoimmune epilepsy mechanisms, neuroprotective therapies (e.g., AP39), and pain modulation via TRP channels. Studies utilize rodent models, monoclonal antibodies, and neurosteroid interventions. Awards : Best Publication in Peer-Reviewed Journal Category (2016) Executive Master of Business Administration (EMBA) (2015) Best Poster Award (2013) Grants & Advising : Accepting PhD students for projects like 'Brain on fire – investigating microglia in epilepsy.' Active in drug discovery collaborations, including patents for Parkinson's therapies. Labs/Teams : Maintains research collaborations with institutions like IISER Pune and the Encephalitis Society (UK). Active in professional bodies such as the Society for Neuroscience.

• Neuroscience
• Neuropharmacology
• Epilepsy Research
• +۴ مورد دیگر

Grant C Churchill is a Professor of Chemical Pharmacology at the University of Oxford, affiliated with New College as a Tutor in Medicine. His research group specializes in understanding cellular calcium signaling, particularly through the second messenger NAADP , and developing chemical tools for drug discovery targeting lysosomal calcium channels and bipolar disorder . Research Focus Churchill’s work spans: Identifying NAADP antagonists like Ned-19 via shape-based virtual screening Repurposing ebselen as a lithium mimetic for bipolar disorder Elucidating lysosomal calcium dysregulation in Niemann-Pick disease and GM2 gangliosidoses Investigating serotonin receptor signaling in psychiatric disorders Key Contributions His group’s discovery of ebselen progressed to phase 2 clinical trials, while acetyl-leucine is being tested for lysosomal diseases. Current projects focus on novel chemical probes for two-pore channels and mechanisms of TFEB activation in neuroprotection.

• Calcium Signaling
• Second Messenger Systems
• Drug Discovery and Repurposing
• +۵ مورد دیگر

Rosario B. Jaime-Lara is an Assistant Professor at the University of California, Los Angeles (UCLA) School of Nursing. She holds advanced degrees including a PhD in Nursing from the University of Pennsylvania, MSN from Columbia University, and dual BS degrees in Nursing and Biological Sciences from University of Pennsylvania and UC Davis. Her research focuses on neurophysiological mechanisms of eating behavior, nutritional disparities in Mexican-American communities, and chemosensory science. Key themes include obesity research, sensory neuroscience, and translational clinical studies. She employs rodent models and clinical research methodologies to explore taste/smell physiology and metabolic health. Jaime-Lara has received over 17 honors including the 2022 Hommer Memorial Award and multiple diversity fellowships. Her work spans interdisciplinary collaborations in genomics, microbiome research, and health IT interventions for chronic disease management. Recent publications emphasize olfactory dysfunction in coronaviruses, fat taste mediators, and metabolic profiling. Her research bridges basic science and clinical practice, with particular attention to underserved populations.

• Nutrition
• Neurophysiology
• Obesity Research
• +۵ مورد دیگر

Erik C. Johnson is Professor and Chair of the Department of Biology at Wake Forest University, College of Arts and Sciences. He holds a Ph.D. and B.A. from the University of Maine and leads a research program focused on neurobiology, molecular signaling, and physiology in Drosophila melanogaster . His work bridges molecular mechanisms with organismal behavior and metabolic regulation. B.A., University of Maine, 1992 Ph.D., University of Maine, 2000 Dr. Johnson's research centers on the neural control of physiology and behavior, with emphasis on neurotransmitter and neuropeptide signaling, biological oscillators, and stress responses. He investigates how G-protein-coupled receptors (GPCRs) regulate neuronal physiology and shape behaviors through receptor desensitization and signaling dynamics. His lab uses Drosophila due to its powerful genetic tools and relevance to conserved biological mechanisms. The recent publications (2010–2023) reflect a strong focus on metabolic regulation, circadian control, neuroendocrine signaling, and sensory biology. Key themes include adipokinetic hormone signaling, AMPK-mediated energy sensing, TRP channel function, and GPCR dimerization. These studies integrate molecular, cellular, and behavioral approaches to dissect conserved physiological pathways. Dr. Johnson has contributed to major reference works such as Hormones, Brain and Behavior and has published in high-impact journals including Cell , PLoS ONE , Journal of Experimental Biology , and Frontiers in Physiology . While no formal awards are listed, his sustained publication record and leadership role indicate significant scholarly recognition. He has mentored numerous students and collaborators, including J.T. Braco, M.J. Rizzo, C.J. Saunders, and others who appear as co-authors on key studies. His research has been supported by internal and external grants, though specific funding sources are not detailed in the text. His lab continues to explore the intersection of neural signaling, metabolism, and behavior. The research is conducted in a molecular and cellular physiology lab within the Department of Biology, utilizing Drosophila genetics, biochemical assays, and behavioral analyses. The team investigates conserved mechanisms of neuronal signaling with implications for human metabolic and neurological disorders.

• Neurobiology
• Physiology
• Molecular Biology
• +۷ مورد دیگر

Barbara Namer is an Adjunct Professor at Friedrich-Alexander University Erlangen-Nuremberg and leads the IZKF-funded "Neuroscience: translational pain research" group at RWTH Aachen University Hospital. Her career spans 20+ years in neurophysiological pain research with clinical translations. Doctor of Medicine (2000-2004), Erlangen-Nuremberg Venia Legendi (Habilitation) in Physiology (2010) Adjunct Professor title (2018) Her research focuses on nociceptor mechanisms in diabetic neuropathy, migraine pathophysiology, and TRPA1 channel dynamics . Computational modeling and human microneurography techniques are central to her work. Key publication trends show expertise in peripheral nerve sensitization , diabetic pain mechanisms , translational pain modeling , and ion channel pharmacology . She has received multiple DGSS and German Neurology Society awards for her pain research. 2019 - DGSS Poster Award 2015 - DGSS Poster Award 2010 - EFIC Grünenthal Grant 2003 & 2018 - German Neurology Society Awards National and international collaborations include research stays in Norway and Sweden, with extensive grant funding from DFG and IZKF projects.

• Translational Pain Research
• Neurophysiology
• Peripheral Nervous System
• +۶ مورد دیگر

Anita L. Zimmerman is a tenured Professor of Molecular Microbiology and Immunology at Brown University’s Warren Alpert Medical School. Since 1987 she has progressed from Assistant to Associate to full Professor, served as Director of the MD/PhD Program (2005–2007), Vice Chair of the Department (2008–2021), and currently directs the Graduate Program in Molecular Pharmacology & Physiology. She also holds the position of Director of Student Welfare in the Therapeutic Sciences Graduate Program. Education PhD, Physiology & Biophysics, University of Miami Miller School of Medicine, 1982 AB, Zoology, University of California, Berkeley, 1978 Research Interests Dr. Zimmerman’s scientific career has centered on the molecular and cellular neurobiology of ion channels . Using patch-clamp electrophysiology, molecular biology, and heterologous expression systems, she has elucidated the mechanisms of cyclic-nucleotide-gated (CNG) channels, TRP channels, and their roles in visual phototransduction , UV-light signaling in melanocytes , and synaptic transmission . Her work has clarified how retinoids modulate CNG channel activity and how mutations in these channels lead to retinal disease. Although she no longer maintains an active wet-lab, she continues to provide critical consultation to ongoing projects at Brown and remains a key mentor in NIH-funded training programs. Scientific Awards & Honors Dean’s Excellence in Teaching Award (multiple years) Graduate School Faculty Award for Advising and Mentoring (2011) Brown Advance Scientific Leadership Award (2009) Salomon Faculty Research Award (1998) Rhode Island Foundation Research Grant (1998) Editorial Board Member, Journal of General Physiology (2006–2017) Council Member, Biophysical Society & Society of General Physiologists Training Grants & Mentorship Dr. Zimmerman co-directs the NIH T32 training grant “Interdisciplinary Training in Pharmacological Sciences” (GM139793, 2021-2026) and previously co-directed its predecessor T32 GM077995. She has mentored numerous MD/PhD and PhD students through the MPP Graduate Program and served as Associate Director and Director of the Brown MD/PhD Program (2000–2007). Laboratory & Team While her independent laboratory is now closed, she collaborates closely with colleagues such as Professor Elena Oancea on NIH-funded projects involving UV phototransduction and ion-channel signaling. She remains an integral part of Brown’s multidisciplinary neuroscience and pharmacology community.

• Ion channel biophysics
• Visual transduction
• Cyclic nucleotide-gated (CNG) channels
• +۵ مورد دیگر

Dr Brent McParland is a Senior Lecturer at the Sydney Pharmacy School, University of Sydney, and a member of the Charles Perkins Centre. His work bridges respiratory pharmacology, parasitology, and reproductive medicine with clinical applications. His primary research investigates mechanisms of exaggerated airway narrowing in asthma and COPD, focusing on airway smooth muscle dynamics, autacoid pharmacology (5HT, NO, Bradykinin, PGs, LTs, Histamine), and the role of extracellular matrix. He also leads pioneering research into whether Australian ticks cause Lyme-like illness, examining Babesia and Theileria pathogens through molecular detection methods. His work extends to reproductive medicine and drugs in sport, aligning with the Charles Perkins Centre's themes of obesity, diabetes, cardiovascular disease, infection, and maternal health. Analysis of his 15 most recent publications reveals a dominant respiratory focus (73% of articles), particularly on airway smooth muscle physiology in asthma/COPD, with significant contributions to parasitology (13%) regarding Australian tick-borne diseases. His methodological approaches emphasize cellular signaling, pathogenesis, and pathology, often utilizing in vitro models and molecular characterization techniques. Dr McParland has secured competitive research funding including: 2014: Australias Lyme-Like Illness grant (Australian Respiratory Council) 2013: NHMRC Project Grant on COPD airway mechanics 2006: Ramaciotti Foundation grant on asthma fluid lining 2006: University of Sydney Newly Appointed Staff grant 2006: Asthma Foundation of NSW award on cold-induced exacerbations He teaches core pharmacology courses including Pharmacology Fundamentals, Respiratory Diseases (Asthma, COPD, PAH), and Autacoid Pharmacology, while contributing to the Charles Perkins Centre's multidisciplinary research on metabolic, infectious, and reproductive health conditions through his expertise in airway pathophysiology and vector-borne disease mechanisms.

• Respiratory Pharmacology
• Parasitology
• Reproductive Medicine
• +۳ مورد دیگر

Dr. Joseph Rower is a Research Assistant Professor in the Department of Pharmacology and Toxicology and Adjunct Assistant Professor in Pediatrics at the University of Utah's College of Pharmacy. He serves as Associate Director of the Center for Human Toxicology. Undergraduate: California Lutheran University, BS in Chemistry and Mathematics Doctoral: University of Colorado Anschutz Medical Campus, PhD in Pharmaceutical Sciences Postdoctoral Fellowships: Systems Biology at University of Colorado, Antiviral Pharmacology at University of Colorado, and Pediatric Clinical Pharmacology at University of Utah Dr. Rower's research focuses on pediatric pharmacology , particularly validating bioanalytical methods for small blood volumes to improve clinical care for children. His lab explores personalized dosing strategies , tacrolimus in pediatric transplantation , (val)ganciclovir for congenital cytomegalovirus , and cannabis pharmacokinetics in adolescents . Collaborative work spans preclinical models, clinical trials, and pharmacometric modeling. Recent publications emphasize pediatric pharmacokinetic-pharmacodynamic relationships , bioanalytical innovations , and personalized medicine applications in diverse areas including infectious disease , neurology , and critical care . Scientific Awards Board-certified clinical pharmacologist (Diplomate of the American Board of Clinical Pharmacology) Dr. Rower's lab within the Center for Human Toxicology integrates bioanalysis and pharmacometrics to identify patient-specific factors affecting drug pharmacokinetics. Collaborations include Dr. Albert Park (pediatric ENT), Dr. Chris Reilly's team (TRP channels and pulmonary toxicology), and international partners via the University of Utah's cores.

• Pharmacokinetics-Pharmacodynamics (PK-PD) Relationships
• Bioanalytical Methods Development
• Pediatric Clinical Pharmacology
• +۷ مورد دیگر

Jan de Hoon serves as a full Professor at KU Leuven's Faculty of Medicine within the Department of Clinical Pharmacology and Pharmacotherapy. He holds dual leadership roles as Head of both the Subdivision and Division of Clinical Pharmacology, and is an active member of the Department of Pharmaceutical and Pharmacological Sciences. His institutional affiliations include membership on the Ethics Committee for Research at UZ/KU Leuven, the Council of the Faculty of Medicine, the POC Geneeskunde, and the Departmental Council. His research centers on TRP channel mechanisms in pain pathways and chemotherapy-induced peripheral neuropathy (CIPN), with significant translational focus from bench to bedside. Key projects include Targeting TRP channels to relief pain (2023-2027) and TRP - Tackling the Roots of Pain (2021-2025). His recent publications demonstrate expertise in neurovascular pharmacology, PET ligand development, and vascular biomarkers for TRP channel functionality. Analysis of his 2024-2025 publications reveals strong emphasis on TRP channel subtypes (TRPA1, TRPV1, TRPM3) in pain mechanisms, vascular readouts for drug effects, and translational models bridging preclinical findings to clinical applications in oncology and neurology. His work frequently employs human tissue studies, healthy volunteer trials, and cancer patient cohorts. As an academic leader, he supervises doctoral candidates including H. Marynissen (2024 thesis on TRP channels in CIPN) and contributes to medical education through courses in Pharmacology, Pharmaceutical Medicine, and Internal Medicine supplements. His research is supported by multiple active grants focusing on TRP channel therapeutics and biomarker development.

• Clinical Pharmacology
• TRP Channels
• Pain Research
• +۴ مورد دیگر

Andres Jara-Oseguera is an Assistant Professor in the Department of Molecular Biosciences within the College of Natural Sciences at the University of Texas at Austin. His research focuses on understanding the molecular mechanisms of ion channel proteins, particularly Transient Receptor Potential (TRP) channels, which are critical for electrical signaling in cells throughout the body. Position: Assistant Professor Department: Molecular Biosciences University: University of Texas at Austin Research Focus: Ion Channel Structure and Function Dr. Jara-Oseguera's research program investigates how molecular machines like ion channels control cellular signaling through their complex three-dimensional structures and dynamic behaviors. His work primarily centers on TRP channels, which play essential roles in biological processes ranging from temperature sensing to pain signaling and inflammatory responses. His laboratory employs a multidisciplinary approach combining structural biology, biophysics, electrophysiology, and molecular biology to elucidate how these channels detect diverse stimuli including temperature, chemical signals, and mechanical forces. The research has significant implications for understanding pain mechanisms and developing novel therapeutic approaches for pain management. An analysis of Dr. Jara-Oseguera's publication record reveals a consistent focus on TRP channel structure-function relationships, with recent work emphasizing temperature sensing mechanisms, channel gating dynamics, and pharmacological modulation. His research demonstrates an evolution from foundational studies on TRPV1 channels toward more sophisticated investigations of TRPM and TRPV2 channel mechanisms using advanced structural and biophysical approaches. The publications highlight his contributions to understanding how these molecular machines integrate multiple signals to control ion flow across membranes. Dr. Jara-Oseguera is actively recruiting students for the 2026-27 academic year, indicating his ongoing commitment to training the next generation of scientists in molecular biosciences. His laboratory provides opportunities for students to engage in cutting-edge research at the intersection of structural biology, biophysics, and neuroscience. The Jara-Oseguera Lab investigates the molecular basis of ion channel function, particularly focusing on how TRP channels serve as biological thermometers and pain sensors. Current projects examine how these channels integrate multiple stimuli, how they detect temperature changes with remarkable sensitivity, and how their subcellular localization influences function in neuronal contexts. The lab employs innovative approaches including high-throughput mutagenesis screens, fluorescence-based biosensors, and electrophysiological techniques to address fundamental questions in ion channel biology.

• Ion Channel Research
• Structural Biology
• Biophysics
• +۶ مورد دیگر

Dr. Gary Lawrence is an Assistant Professor of Molecular Neurobiology in the School of Biotechnology at Dublin City University (DCU). His research focuses on functional neurobiology, particularly the role of neurotoxins like botulinum in understanding nervous system function and therapeutic applications for peripheral neuropathies. He holds a doctorate from Imperial College London, where he studied SNARE proteins in neurotransmitter release. Lawrence joined DCU in 2003 as a Research Lecturer and transitioned to his current role in 2023. His work investigates botulinum toxin effects on peripheral nerve types (motor, sympathetic, parasympathetic, sensory) and processes like synaptic transmission, neuropeptide exocytosis, and TRP channel signaling in pain pathways. Education: PhD in Molecular Neurobiology from Imperial College London, followed by postdoctoral research there. Professional trajectory includes foundational roles in DCU’s International Centre for Neurotherapeutics established by Prof. Oliver Dolly. Research interests emphasize botulinum toxin mechanisms, TRP channels in pain signaling, and membrane trafficking. Recent studies explore how TRP channels encode pain intensity and are modulated by neurotrophins. His lab uses primary neuron cultures, in vivo models, and toxin-based tools to dissect neuron-specific exocytosis pathways and SNARE protein roles. Publications highlight advancements in toxin-based therapeutics, neuron type-specific effects, and pain signaling mechanisms. Collaborative efforts focus on translating neurotoxin research into clinical applications for neuropathic pain and autonomic disorders. Lab/Team: Part of the International Centre for Neurotherapeutics at DCU, specializing in neurotoxin research and neuropharmacology.

• Molecular Neurobiology
• Neurotoxins
• Neurotransmission
• +۳ مورد دیگر

Prof. Dr. Antonella Di Pizio (born 1984) is an Associate Professor for Chemoinformatics and Protein Modelling at the Department of Molecular Life Sciences within the TUM School of Life Sciences at the Technical University of Munich. Since 2018, she has led the Molecular Modeling group at the Leibniz Institute of Food Systems Biology at TUM in Freising, Germany. Her academic journey includes a PhD in Pharmaceutical Sciences from the University of Chieti, Italy (2012), followed by research at Philipps University in Marburg, Germany, and a postdoc position at the Hebrew University of Jerusalem, Israel. Prof. Di Pizio's research focuses on computational approaches to understanding chemosensory G protein-coupled receptors (GPCRs), particularly taste and smell receptors. Her work combines molecular modeling, chemoinformatics, and structural bioinformatics to investigate the molecular basis of ligand recognition and activation mechanisms. Her group develops predictive models for screening and designing bioactive compounds relevant to food reformulation and therapeutic applications. Analysis of Prof. Di Pizio's publication record reveals a strong focus on bitter taste receptors, particularly TAS2R family members, and odorant receptors. Her research spans computational modeling of receptor-ligand interactions, development of predictive algorithms for taste compound identification, and investigation of the structural basis of chemosensory perception. Recent work demonstrates increasing integration of machine learning approaches with traditional molecular modeling techniques. Scientific Recognition: Leibniz Best Minds Programme for Women Professors (2022) Platinum Manfred Rothe Excellence Award in Flavor Research (2019) Bernardo Nobile doctorate award VIII Edition (2013) Keystone Symposia Future of Science Fund Fellowship (2017) Prof. Di Pizio serves on the editorial board of Frontiers in Molecular Biosciences and is a Working Group Leader and Management Committee member of the ERNEST Cost Action CA18133. She teaches courses including 'Modeling and simulations of Biological Macromolecules' and 'Drug and Protein Design' at TUM. Her Molecular Modeling group collaborates extensively with other research groups at the Leibniz-LSB@TUM on interdisciplinary projects focused on food systems biology. The Molecular Modeling group, established relatively recently at the institute, investigates food-relevant molecules and their interactions using computational tools including molecular docking, molecular dynamics simulations, pharmacophore modeling, QSAR, machine learning, and virtual screening. Their work aims to develop next-generation methodologies for food design that address current challenges in the food system.

• Computational Chemistry
• Molecular Modeling
• GPCR Research
• +۵ مورد دیگر

David T. Lodowski is an active Assistant Professor at Case Western Reserve University School of Medicine holding multiple appointments across the Department of Nutrition, Center for Proteomics and Bioinformatics, and Department of Pharmacology. He also serves as Director of the Biomedical Sciences Training Program. His laboratory focuses on elucidating the structural mechanisms of G protein-coupled receptors (GPCRs) and related signaling pathways using advanced structural biology techniques. Dr. Lodowski completed his BS in cellular and molecular biology from Tulane University in 1998, followed by a PhD in Biochemistry from the University of Texas at Austin in 2005. He then completed a postdoctoral fellowship in the Palczewski Laboratory at Case Western Reserve University from 2005-2011, where he examined structural changes in bovine rhodopsin during photoactivation and GPCR activation. His research primarily centers on GPCR signaling dynamics, utilizing X-ray crystallography, electron microscopy, and structural mass spectrometry to study macromolecular complexes. Additional research projects include developing biosensors for markers of hypoxia and fatigue, and investigating aquaporins as membrane gas channels. Dr. Lodowski teaches SYBB 501 Systems Biology & Bioinformatics Journal Club and CBIO 455 Molecular Biology I courses. Analysis of his recent publications shows a strong focus on structural biology of membrane proteins, particularly GPCRs and ion channels, with increasing emphasis on protein footprinting techniques and biosensor development. His work bridges structural biology with physiological applications, demonstrating translational potential in understanding cellular signaling pathways. Awards and Honors: Mt. Sinai Scholar (2012) Current Funding: Biosis AFRL as associate project lead since July 15, 2020. Dr. Lodowski has mentored students through the Biomedical Sciences Training Program which he directs. His laboratory has determined numerous protein structures (including IDs 5HI9, 4X1H, 4YEU, and others) related to GPCR signaling pathways. His research team employs a multidisciplinary approach combining structural biology, biophysics, and biochemistry to investigate the molecular mechanisms underlying GPCR activation and signaling, with implications for understanding numerous physiological processes and developing targeted therapeutics.

• Structural Biology
• G Protein-Coupled Receptors (GPCRs)
• X-ray Crystallography
• +۵ مورد دیگر